NXTC logo
NXTC NASDAQ US

NextCure, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO May 2019
$10.72
▲ +$0.19 (+1.80%)
Vol 11K
2
Quality Score
fail
Mkt Cap
$49.7M
ROE
-131.4%
Margin
-65.2%
D/E
0.00
Beta
1.57
52W
$3–$16

Wall Street Consensus

9 analysts · Apr 2026
3
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating

Price Chart

Similar Stocks

ATRA
Atara Biotherapeutics Inc
P/E 5.6
$130.4M
LITS
Lite Strategy Inc
$48.6M
SNSE
Sensei Biotherapeutics Inc
$13.5M
CELU
Celularity Inc
$31.6M
CRVO
CervoMed Inc
$73.1M
RNXT
RenovoRx Inc
$30.8M
PDSB
PDS Biotechnology Corp
$42.1M
XLO
Xilio Therapeutics Inc
$33.6M

Earnings

Beat rate: 75.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-2.47 $-0.81 +$1.66
Sep 2025 $-4.06 $-3.22 +$0.84
Jun 2025 $-4.71 $-11.29 $-6.58
Mar 2025 $-4.90 $-4.68 +$0.22

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -106.6% -106.6% -106.6% -106.6% -131.4% -131.4%
P/E (TTM) — — — — — —
Net Margin — -65.2% -65.2% -65.2% -65.2% -65.2%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 3.71 3.71 3.71 3.71 2.97 2.97

Key Ratios

ROA (TTM)
-98.6%
P/S (TTM)
1.82
P/B
0.3
EPS (TTM)
$-24.19
CF/Share
$-2.22
52W High
$15.74
52W Low
$2.69
$2.69 52-Week Range $15.74

How does NXTC compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

NXTC AAPG ABEO ABOS ABP

NXTC valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
1.8
▼ 86% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
0.3
▼ 87% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

NXTC profitability vs Biotechnology peers

ROE
-131.4%
▼ 95% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-65.2%
▲ 77% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-98.6%
▼ 111% below peers (-46.7%)
vs Peers
vs Industry
Weak

NXTC financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.0
▼ 33% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.6
▲ 61% above peers (1.0)
vs Peers
vs Industry
More volatile

NXTC fundamentals radar

NXTC Peer median Industry

NXTC profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

NXTC vs peers: key metrics

Latest News

No related news yet